Could an Opioid Addiction Drug Hold the Key to Treating Stimulant Use Disorder?
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A nationwide Finnish register study of 282,307 adults examines how sociodemographic and socioeconomic factors shape who uses anti-obesity medications.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine